article thumbnail

Pharmacies Need Strategies to Improve Health Care Access

Pharmacy Times

Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. Offering and promoting immunizations and point-of-care testing are 2 proven ways to address SDOH.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

From 2003 to 2023, 943 drugs were approved through the 505(b)(2) pathway. As of January 1, 2023, CMS has begun issuing unique J-codes to 505(b)(2) drugs dating back to 2003. “In However, 505(b)(2) drugs have been available since the 1980s. “CMS

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Do We Really Pay More for Prescription Drugs in the United States?

Pharmacy Times

Bush’s Medicare Modernization Act (MMA) of 2003, and with it drug coverage for tens of millions of Medicare enrollees for the first time in program history. From a coverage perspective, Part D has been a success, with older Americans paying far less for drugs than they otherwise would have prior to MMA 2003. Add President Joseph R.

article thumbnail

The Role of Pharmacists in Cardiovascular Health: A Collaborative Approach to Treatment, Counseling, and Nutrition

Pharmacy Times

J Am Pharm Assoc (2003). 2022;28(11):2238-2240. doi:10.1038/s41591-022-02027-3. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. 2009;49(3):383-391. doi:10.1331/JAPhA.2009.09015 2009.09015 Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O'Connor SK.

article thumbnail

Zydus gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg

Express Pharma

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. The group now has 387 approvals and has so far filed over 460* ANDAs since the commencement of the filing process in FY 2003-04.

Immunity 104
article thumbnail

Zydus receives USFDA approval for Dexamethasone

Express Pharma

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer and immune system disorders. The product will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

Granzyme B is an enzyme released by activated immune cells and using this as a in vivo imaging biomarker has great potential to monitor immune cell activation in a variety of inflammatory diseases, autoimmune diseases, cancer and infections. Barrett at the Center for Gamma Ray Imaging.